Macrophage activation syndrome triggered by primary disseminated toxoplasmosis

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 12, 2012, Pages 1001-1004

  Arslan, Ferhat ^a   Batirel, Ayse ^a   Ramazan, Mehmet ^b   Ozer, Serdar ^a   Mert, Ali ^c  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Haemophagocytosis; Intravenous immunoglobulin; Macrophage activation syndrome; Toxoplasma

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINUCLEAR ANTIBODY; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; COTRIMOXAZOLE; FERRITIN; GLOBULIN; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISOLONE; PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIMICROBIAL THERAPY; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW BIOPSY; CASE REPORT; CELIAC DISEASE; CERVICAL LYMPHADENOPATHY; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COUGHING; ECHOGRAPHY; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HERPES SIMPLEX; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MACULOPAPULAR RASH; MAJOR DEPRESSION; MALAISE; NEUTROPHIL COUNT; PHAGOCYTOSIS; PHYSICAL EXAMINATION; PNEUMONIA; SEDIMENTATION; SORE THROAT; STEROID THERAPY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TOXOPLASMOSIS;

ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; LYMPHATIC DISEASES; MACROPHAGE ACTIVATION SYNDROME; MIDDLE AGED; NECK; PNEUMONIA; TOXOPLASMOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84874165292     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.691208     Document Type: Article

References (11)

1. Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010;153:109-20.
2. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: Current concepts and challenges ahead. Swiss Med Wkly 2005;135:299-314.
3. Ramanan AV, Baildam EM. Macrophage activation syndrome is hemophagocytic lymphohistiocytosis - need for the right terminology. J Rheumatol 2002;29:1105, author reply 1105.
4. Sanchez A, Celaya AK, Victorio A. Histoplasmosis-associated hemophagocytic syndrome: A case report. AIDS Read 2007; 17:496-9.
5. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 7 th ed. Vol. 2. Philadelphia, PA: Elsevier Health Science; 2010.
6. Leal FE, Cavazzana CL, de Andrade HF Jr, Galisteo AJ Jr, de Mendon ç a JS, Kallas EG. Toxoplasma gondii pneumonia in immunocompetent subjects: Case report and review. Clin Infect Dis 2007;15;44:62-6.
7. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
8. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011 Oct 13;118(15): 4041-52. Epub 2011 Aug 9.
9. Ost A, Nilsson-Ardnor S, Henter JI. Autopsy fi ndings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology 1998;32:310-6.
10. Kim JM, Kwok SK, Ju JH, Park KS, Park GS, Kim HY, Park SH. Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy. Rheumatol Int. 2010 Dec 1. [Epub ahead of print]
11. Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001;68:4-10.